王艳明导师简介
照片
姓名：王艳明
性别：女
出生年月：1987年5月
学位、学历：博士/研究生
职称：副教授
七、学术兼职情况
八、基本情况
1. 2008-2012年毕业于bat365在线平台官方网站药学院药学专业，获理学学士，2012年-2015年毕业于bat365在线平台官方网站药学院药理学专业，2017-2020年毕业于新疆医科大学药学院药理学专业。
2.2021年获硕士生导师招生资格。
3.主要研究内容：心血管药理学
4. 近五年代表性科研成果
[1] YM Wang, YC Wu, J Sailike, et al. Fourteen composite probiotics alleviate type 2 diabetes through modulating gut microbiota and modifying M1/M2 phenotype macrophage in db/db mice[J].Pharmacological Research,2020,161:105150. (SCI收录)
[2] YM Wang, D Dilidaxi, YC Wu, et al. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomedicine & Pharmacotherapy,2020,125:109914. (SCI收录)
[3] YM Wang, J Ma, XY Yan, et al. Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis via Alleviating Hypoxia and Reducing Glycolysis in Melanoma B16F10 Cells[J]. Recent Pat Anticancer Drug Discov.2016;11(2):215-27. (SCI收录)
[4] YC Wu, YM Wang, Nabi Xinhua. Ziziphora clinopodioides flavonoids based on network pharmacology attenuates atherosclerosis in rats induced by High-fat emulsion combined with Vitamin D3 by down-regulating VEGF/AKT/NF-κB signaling pathway[J]. Biomedicine & Pharmacotherapy, 2020,129:110399. (SCI收录)
[5] Yuche Wu, Yanming Wang, Nabi Xinhua. Protective effect of Ziziphora clinopodioides flavonoids against H2O2-induced oxidative stress in HUVEC cells[J]. Biomedicine & Pharmacotherapy,2019,117:109156.(SCI收录)
联系方式:
电子信箱：wangyanminglyo@163.com
